Carson Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$385K Buy
5,367
+400
+8% +$30.8K 0.2% 106
2025
Q4
$394K Sell
4,967
-100
-2% -$7.88K 0.2% 98
2025
Q3
$382K Sell
5,067
-300
-6% -$20.6K 0.21% 103
2025
Q2
$370K Sell
5,367
-600
-10% -$39.3K 0.24% 99
2025
Q1
$404K Sell
5,967
-500
-8% -$29.9K 0.27% 84
2024
Q4
$290K Buy
+6,467
New +$363K 0.2% 120
2024
Q2
Sell
-2,998
Closed -$239K 169
2024
Q1
$239K Sell
2,998
-93
-3% -$7.1K 0.17% 144
2023
Q4
$244K Sell
3,091
-1,031
-25% -$73.4K 0.19% 131
2023
Q3
$288K Sell
4,122
-475
-10% -$33.7K 0.25% 107
2023
Q2
$318K Buy
+4,597
New +$327K 0.27% 102

Other funds holding CVS

Carson Advisory's CVS Position: Q1 2026 in Review

Carson Advisory increased its CVS Health (CVS) stake by 8.1% in Q1 2026, buying an estimated $30.8K and bringing the position to 5,367 shares worth $385K. The position accounts for 0.2% of the portfolio, ranked #106.

Carson Advisory first reported a position in CVS in Q2 2023 and has held it in 10 quarters since. The position peaked at $404K in Q1 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Carson Advisory held 5,367 shares of CVS Health worth $385K as of Q1 2026.
  • Carson Advisory bought 400 CVS Health shares in Q1 2026, an estimated $30.8K.
  • CVS Health made up 0.2% of Carson Advisory's portfolio in Q1 2026, its #106 holding.
  • Carson Advisory first reported a position in CVS Health in Q2 2023 and has held it in 10 quarters since.
  • Carson Advisory's CVS Health position peaked at $404K in Q1 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.